CPT Code Overview

CPT 89321 describes a semen analysis focused on the presence and/or motility of sperm, performed as part of reproductive medicine laboratory testing. This procedure falls under Pathology and Laboratory Procedures with a subcategory in Reproductive Medicine Procedures. Typical sites of service include a laboratory (CLIA-certified setting) and it is often billed in office or outpatient laboratory settings.

Clinical Context

A male patient of reproductive age presents to a fertility clinic or primary care office for evaluation of infertility or abnormal semen parameters. The clinician documents symptoms or history such as difficulty conceiving, prior abnormal semen testing, or a diagnosis code like N46.9 (male infertility) or encounter for fertility testing Z31.41. The patient provides a semen specimen at a CLIA-certified laboratory or an outpatient office laboratory. Specimen collection is performed according to institutional protocol (abstinence interval, container labeling, and timely transport). The laboratory performs a semen analysis focused on the presence and/or motility of sperm using microscopy and standardized reporting. Results are reviewed by the ordering provider—often a urologist or obstetrics & gynecology specialist—and used alongside history, physical exam, and additional testing to guide further evaluation.

Coding Specifications

Modifier 26 is used for the professional component when a reporting clinician (pathologist, laboratory physician, or other qualified professional) interprets or reviews the semen analysis and documents the professional input.

Modifier TC is used for the technical component when the laboratory or facility performs the specimen processing, microscopy, and reporting without a separately billed professional interpretation.

• Associated provider taxonomies:

• Notes:

• Use 26 when billing only the professional interpretation portion of the service.

• Use TC when billing only the technical laboratory work.

• Use both components per payer guidance when services are split and allowed.

Related Diagnoses

• N46.9 — Male infertility, unspecified

  Clinical relevance: Indicates male factor infertility as an indication for semen analysis to evaluate sperm presence and motility.

• Z31.41 — Encounter for fertility testing

  Clinical relevance: Represents a visit for fertility evaluation; semen analysis is commonly ordered during such encounters.

• N46.01 — Azoospermia

  Clinical relevance: Defines absence of sperm in ejaculate; semen analysis documenting absence supports this diagnosis and guides further workup.

• N46.11 — Oligospermia

  Clinical relevance: Low sperm concentration identified by semen analysis; motility assessment complements the diagnosis.

• N46.8 — Other male infertility

  Clinical relevance: Captures other specified male infertility conditions where semen analysis for presence and motility contributes to evaluation.

Related CPT Codes

• 89320 is a more comprehensive semen analysis including volume, sperm count, motility, and differential; it is often used when a full quantitative report is required beyond presence/motility.

• 89322 is used when strict morphologic criteria (for example, Kruger strict morphology) are required; this is an alternative when morphology assessment affects clinical decision-making.

• 89310 focuses on motility and count without the postcoital/Huhner component and may be used in workflows that do not require volume or differential.

• 89300 includes presence and/or motility of sperm in the context of a Huhner (postcoital) test and is used for postcoital testing rather than routine semen analysis.

• Codes 89320, 89322, and 89310 are commonly used as alternatives to 89321 when additional parameters (volume, count, strict morphology, or differential) are required. 89300 is used in specific postcoital testing workflows.

The national mean for BUCA (average commercial) is $12.04, which is modestly higher than Medicare's reported value in the table ($0.00), indicating Medicare data is not available in the input. Cigna's mean rate of $15.50 is the highest among the listed commercial payers, while UnitedHealth Group's mean of $10.18 is the lowest.

Rate dispersion (P75 minus P25) is widest for Cigna (9.5) and BCBS (4.73), indicating greater variability in negotiated rates; the tightest distributions are seen with Aetna (4) and UnitedHealth Group (6.5). The table and chart below present the full breakdown of national mean rates and percentile values.